Study of immune-tolerized cell lines and extracellular vesicles inductive environment promoting continuous expression and secretion of HLA-G from semiallograft immune tolerance during pregnancy

References

• Tetta C, Ghigo E, Silengo L, et al. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine. 2013;44:11–19.
   PubMed Web of Science ®Google Scholar
• Arslan F, Lai RC, Smeets MB, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013;10:301–312.
   PubMed Web of Science ®Google Scholar
• Gallina C, Turinetto V, Giachino C. A new paradigm in cardiac regeneration: the mesenchymal stem cell secretome. Stem Cells Int. 2015;2015:765846.
   PubMed Web of Science ®Google Scholar
• Kordelas L, Rebmann V, Ludwig AK, et al. MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28:970–973.
   PubMed Web of Science ®Google Scholar
• Bruno S, Grange C, Collino F, et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One. 2012;7:e33115.
   PubMed Web of Science ®Google Scholar
• Tan CY, Lai RC, Wong W, et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 2014;5:76.
   PubMed Web of Science ®Google Scholar
• Xin H, Li Y, Buller B, et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012;30:1556–1564.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, et al. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2014;23:1233–1244.
   PubMed Web of Science ®Google Scholar
• Liu Q, Rojas-Canales DM, Divito SJ, et al. Donor dendritic cell-derived exosomes promote allograft-targeting immune response. J Clin Invest. 2016;126:2805–2820.
   PubMed Web of Science ®Google Scholar
• Cataldi M, Vigiotti C, Mosca T, et al. Emerging role of the spleen in the pharmacokinetics of monoclonal antibodies, nanoparticles and exosome. Int J Mol Sci. 2017;18:1249.
   Web of Science ®Google Scholar
• Wang D, Quan Y, Yan Q, et al. Targeted disruption of the β2-microglobulin gene minimizes the immunogenicity of human embryonic stem cells. Stem Cells Transl Med. 2015;4:1234–1245.
   Web of Science ®Google Scholar
• Xu H, Wnag B, Ono M, et al. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell. 2019;24:566–578.
   PubMed Web of Science ®Google Scholar
• Gornalusse GG, Hirata RK, Funk S, et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol. 2017;35:765–772.
   PubMed Web of Science ®Google Scholar
• Deuse T, Hu X, Gravina A, et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat Biotechnol. 2019;37:252–258.
   PubMed Web of Science ®Google Scholar
• Ellis SA, Sargent IL, Redman CW, et al. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology. 1986;59:595–601.
   Web of Science ®Google Scholar
• Carosella ED, Moreau P, Le Maoult J, et al. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol. 2003;81:199–252.
   PubMed Web of Science ®Google Scholar
• Gregori S, Tomasoni D, Pacciani V, et al. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood. 2010;116:935–944.
   PubMed Web of Science ®Google Scholar
• Amodio G, Mugione A, Sanchez AM, et al. HLA-G expressing DC-10 and CD4+ T cells accumulate in human decidua during pregnancy. Hum Immunol. 2013;74:406–411.
   PubMed Web of Science ®Google Scholar
• Amodio G, Sales de Albuquerque R, Gregori S. New insights into HLA-G mediated tolerance. Tissue Antigens. 2014;84:255–263.
   PubMedGoogle Scholar
• Castelli EC, Veiga-Castelli LC, Yaghi L, et al. Transcriptional and Posttranscriptional Regulations of the HLA-G gene. J Immunol Res. 2014;2014:734068.
   PubMed Web of Science ®Google Scholar
• Bax BE, Bloxam DL. Energy metabolism and glycolysis in human placental trophoblast cells during differentiation. Biochim Biophys Acta. 1997;1319:283–292.
   PubMed Web of Science ®Google Scholar
• Hunt JS. Stranger in a strange land. Immunol Rev. 2006;213:36–47.
   PubMed Web of Science ®Google Scholar
• Hannan NJ, Paiva P, Dimitriadis E, et al. Models for study of human embryo implantation: choice of cell lines? Biol Reprod. 2010;82:235–245.
   PubMed Web of Science ®Google Scholar
• Apps R, Gardner L, Sharkey AM, et al. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol. 2007;37:1924–1937.
   Web of Science ®Google Scholar
• Gonen-Gross T, Achdout H, Gazit R, et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J Immunol. 2003;171:1343–1351.
   Web of Science ®Google Scholar
• Giuliani M, Fleury M, Vernochet A, et al. Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation. PLoS ONE. 2011;6:e19988.
   PubMed Web of Science ®Google Scholar
• Wood KJ, Issa F, Hester J. Understanding stem cell immunogenicity in therapeutic applications. Trends Immunol. 2016;37:5–16.
   PubMed Web of Science ®Google Scholar
• LeMaoult J, Daouya M, Wu J, et al. Synthetic HLA-G protein for therapeutic use in transplantation. Faseb J. 2013;27:3643–3651.
   Web of Science ®Google Scholar
• Leisegang MS, Gu L, Preussner J, et al. The histone demethylase PHF8 facilitates alternative splicing of the histocompatibility antigen HLA-G. FEBS Lett. 2019;593:487–498.
   Web of Science ®Google Scholar
• Manaster I, Goldman-Wohl D, Greenfield C, et al. MiRNA-mediated control of HLA-G expression and function. PLoS ONE. 2012;7:e33395.
   Web of Science ®Google Scholar
• Vashukova ES, Glotov AS, Baranov VS. MicroRNAs associated with preeclampsia. Russian J Genetics. 2020;56:1–16.
   Web of Science ®Google Scholar
• Guan Z, Song B, Liu F, et al. TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells. J Biomed Sci. 2015;22:107.
   Web of Science ®Google Scholar
• Rouas-Freiss N, Moreau P, LeMaoult J, et al. The dual role of HLA-G in cancer. J Immunol Res. 2014;2014:359748.
   PubMed Web of Science ®Google Scholar
• Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186:1809–1818.
   PubMed Web of Science ®Google Scholar
• Colonna M, Samaridis J, Cella M, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 1998;160:3096–3100.
   PubMed Web of Science ®Google Scholar
• Ho Wang Yin KY, Loustau M, Wu J, et al. Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Cell Mole Life Sci. 2012;69:4041–4049.
   Web of Science ®Google Scholar
• Shiroishi M, Kuroki K, Ose T, et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem. 2006;281:10439–10447.
   PubMed Web of Science ®Google Scholar
• Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, et al. HLA-G: an immune checkpoint molecule. Adv Immunol. 2015;127:33–144.
   PubMed Web of Science ®Google Scholar
• Manavalan JS, Rossi PC, Vlad G, et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol. 2003;11:245–258.
   PubMed Web of Science ®Google Scholar
• Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087.
   PubMed Web of Science ®Google Scholar
• Rebmann V, Konig L, Nardi Fda S, et al. The potential of HLA-G-bearing extracellular vesicles as a future element in HLA-G immune biology. Front Immunol. 2016;7:173.
   Web of Science ®Google Scholar
• Alegre E, Rebmann V, Lemaoult J, et al. In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes. Eur J Immunol. 2013;43(7):1933–1939. .
   Web of Science ®Google Scholar
• Veit TD, Chies JAB, Switala M, et al. The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. PLoS One. 2015;10:e0123838.
   Google Scholar